Open access · OA via OpenAlex

Rapamycin for aging stem cells

William S. Hambright, Marc J. Philippon, Johnny Huard

Aging · 2020 · ▲ 13 citations

Stem-cell exhaustion Rapamycin / mTOR inhibition

Abstract

This 2020 study published in Aging examines the effects of mTOR-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin on the aging process of stem cells. The research discusses cellular mechanisms.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.18632/aging.103816
Canonical: link ↗
Fetched: 2026-10-06 MST

Cite this

APA

Hambright, W.S., Philippon, M.J., & Huard, J. (2020). Rapamycin for aging stem cells. <em>Aging</em>. https://doi.org/10.18632/aging.103816

Vancouver

Hambright WS, Philippon MJ, Huard J. Rapamycin for aging stem cells. Aging. 2020. doi:10.18632/aging.103816.

BibTeX

@article{william2020Rapamy, title = {Rapamycin for aging stem cells}, author = {William S. Hambright and Marc J. Philippon and Johnny Huard}, journal = {Aging}, year = {2020}, doi = {10.18632/aging.103816}, }